HealthEquity (HQY) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.24
- Estimate
- $1.19
- Surprise
- +3.9%
- Revenue (period 2026-07-31)
- $350.7M
- Score today
- 6.0/10
Revenue source: xbrl.
How the report landed
HealthEquity (HQY) beat the $1.19 estimate with adjusted EPS of $1.24 — a clear 3.9% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates HQY Hold at 6.0/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +3.9% surprise compares with a +7.9% four-quarter average. Next scheduled report: 2026-12-02.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.9 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Product: HSAs and other CDBs
- Thin upside margin: 7.1%
- Reward/Risk 0.6:1 at current price — below 1.5:1 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $101.36
- Price target
- $108.60
- Stop
- $95.56
- Upside to target
- +7.1%
- Reward-to-risk
- 0.6:1
The stock trades at 36.6× trailing but 18.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 70 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-10-30 — shown for context, not personalized investment advice.
HQY at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $8.38B
- P/E (fwd)
- 18.4
- P/E (ttm)
- 36.6
- 52-week range
- $72.76–$107.62
- Off 52-week high
- 5.8%
- RSI (14)
- 70
- Volume vs avg
- 0.78×
- Score today
- 6.0/10